The disease arises from either reduced insulin secretion by pancreatic β-cells (type 1 diabetes) or impaired tissue responsiveness to insulin (type 2 diabetes [T2D]) (Kumar et al. 2020). Here, INS is linked to type 1 diabetes mellitus.